Showing 35,297 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

History of HIV & AIDS

How mass rape in genocide transformed Rwanda's response to AIDS

Editor's pick
Reuters
11 April 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Antibody-based treatment

Monoclonal antibody may lead to long-term viral load reduction

News
11 April 2019
Organ transplants

This doctor saves lives through organ transplants – and he's also a world-class dancer

Editor's pick
From the Grapevine
10 April 2019
Migrants, refugees & displaced people

Autopsy: Migrant detainee died from AIDS complications

Editor's pick
San Francisco Chronicle
10 April 2019
PrEP policies & guidelines

PrEP: Camden councillor Jonathan Simpson urges NHS to extend availability of preventative HIV drug

Editor's pick
Ham & High
10 April 2019
People who inject drugs

Cocaine injecting and homelessness 'behind Glasgow HIV rise'

Editor's pick
BBC News
10 April 2019
Vaccinations & immunisations

HPV vaccination for gay men effectively delivered in sexual health and HIV clinics

News
10 April 2019
Government, leadership & policy

US: How HHS Secretary Alex Azar Reconciles Medicaid Cuts With Stopping The Spread Of HIV

Editor's pick
NPR
9 April 2019
PrEP science

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

Editor's pick
The Body
9 April 2019
Hepatitis & HIV

Summary from CROI 2019 for viral Hepatitis, from Jürgen Rockstroh

Editor's pick
NATAP
9 April 2019
Hepatitis C treatment

Hepatitis C deaths fall by 16 per cent between 2015 and 2017

Editor's pick
Public Health England
9 April 2019
People & personal stories

Gregg Gonsalves Blends Activism and Science

Editor's pick
The New York Times
9 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
PrEP programmes & uptake

Racism, marginalisation and PrEP stereotypes affect PrEP uptake for black MSM in London

News
9 April 2019
Employment

Employers’ unlawful vetting of job applicant health conditions and disabilities persists, says NAT

Editor's pick
National AIDS Trust
8 April 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
TB diagnosis

Xpert testing to find TB in people with advanced HIV at diagnosis saves lives, study finds

Editor's pick
Science Speaks
8 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
Hepatitis C transmission & prevention

English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

News
7 April 2019
Government, leadership & policy

The World’s Largest HIV Epidemic in Crisis: HIV in South Africa

Editor's pick
Center for Strategic and International Studies
5 April 2019
Migrants, refugees & displaced people

UK: Ministers accused of cover-up over migrant health reports

Editor's pick
The Guardian
5 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
Treatment guidelines

Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Editor's pick
MedPage Today
5 April 2019